Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product & Service
2.3.2 Market Size By Syndrome/Disease Type
2.3.2 Market Size By Technology
2.3.2 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Global Incidence and Prevalence of Syndromic Diseases (2024)
4.1.1 Respiratory Infections
4.1.2 Gastrointestinal Infections
4.1.3 Sexually Transmitted Infections
4.1.4 Central Nervous System Infections
4.2 Device Volume, Global Overview (2020–2032)
4.2.1 Annual Unit Sales Volume by Syndromic Panel Type
4.2.2 Installed Base of Multiplex Diagnostic Systems
4.2.3 Adoption in Hospital vs. Non-Hospital Settings
4.3 Healthcare Spending Overview (2024)
4.3.1 Government Healthcare Investments in Molecular Diagnostics
4.3.2 Commercial and Private Insurance Coverage for Syndromic Panels
4.3.3 Out-of-Pocket Trends in Diagnostic Testing
5. Syndromic Multiplex Diagnostics Market Segmental Analysis & Forecast, By Product & Service, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Reagents & Consumables
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Instruments/Systems
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Software & Services
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
6. Syndromic Multiplex Diagnostics Market Segmental Analysis & Forecast, By Syndrome/Disease Type, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Respiratory Infections
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Gastrointestinal Infections
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Sexually Transmitted Infections (STIs)
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
6.5 Bloodstream Infections
6.5.1 Key Trends
6.5.2 Market Size & Forecast, 2021 – 2032
6.6 Central Nervous System (CNS) Infections
6.6.1 Key Trends
6.6.2 Market Size & Forecast, 2021 – 2032
6.7 Urinary Tract Infections (UTIs)
6.7.1 Key Trends
6.7.2 Market Size & Forecast, 2021 – 2032
6.8 Others
6.8.1 Key Trends
6.8.2 Market Size & Forecast, 2021 – 2032
7. Syndromic Multiplex Diagnostics Market Segmental Analysis & Forecast, By Technology, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 PCR-based
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Microarrays
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Next-Generation Sequencing (NGS)
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.5 Isothermal Nucleic Acid Amplification
7.5.1 Key Trends
7.5.2 Market Size & Forecast, 2021 – 2032
7.6 Other Molecular Diagnostic Technologies
7.6.1 Key Trends
7.6.2 Market Size & Forecast, 2021 – 2032
8. Syndromic Multiplex Diagnostics Market Segmental Analysis & Forecast, By End User, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospitals & Clinics
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Diagnostic Laboratories
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Research & Academic Institutions
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Others (e.g., Ambulatory Centers)
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
9. Syndromic Multiplex Diagnostics Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.2.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.2.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.2.5 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.2.6 Syndromic Multiplex Diagnostics Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.2.6.1.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.2.6.1.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.2.6.1.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.2.6.2.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.2.6.2.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.2.6.2.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.3.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.3.5 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.3.6 Syndromic Multiplex Diagnostics Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.1.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.3.6.1.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.1.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.2.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.3.6.2.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.2.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.3.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.3.6.3.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.3.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.4.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.3.6.4.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.4.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.5.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.3.6.5.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.5.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.6.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.3.6.6.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.6.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.7.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.3.6.7.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.7.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.3.6.8.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.3.6.8.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.8.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.4.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.4.5 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.4.6 Syndromic Multiplex Diagnostics Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.1.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.4.6.1.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.1.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.2.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.4.6.2.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.2.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.3.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.4.6.3.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.3.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.4.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.4.6.4.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.4.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.5.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.4.6.5.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.5.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.6.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.4.6.6.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.6.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.4.6.7.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.4.6.7.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.7.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.5.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.5.5 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.5.6 Syndromic Multiplex Diagnostics Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.1.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.5.6.1.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.1.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.2.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.5.6.2.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.2.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.3.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.5.6.3.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.3.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.4.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.5.6.4.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.4.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.5.6.5.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.5.6.5.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.5.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.6.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.6.5 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.6.6 Syndromic Multiplex Diagnostics Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.1.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.6.6.1.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.1.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.2.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.6.6.2.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.2.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.3.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.6.6.3.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.3.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.4.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.6.6.4.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.4.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.5.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.6.6.5.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.5.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Syndromic Multiplex Diagnostics Market Size & Forecast, By Product & Service, 2021 – 2032
9.6.6.6.2 Syndromic Multiplex Diagnostics Market Size & Forecast, By Syndrome/Disease Type, 2021 – 2032
9.6.6.6.3 Syndromic Multiplex Diagnostics Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.6.4 Syndromic Multiplex Diagnostics Market Size & Forecast, By End User, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 bioMérieux SA
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Luminex Corporation (a DiaSorin company)
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 QIAGEN N.V.
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 BioFire Diagnostics (a bioMérieux company)
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 GenMark Diagnostics
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Hologic Inc.
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 F. Hoffmann-La Roche Ltd
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Thermo Fisher Scientific Inc.
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Siemens Healthineers
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Abbott Laboratories
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Becton, Dickinson and Company (BD)
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Mobidiag Ltd (part of Hologic)
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Seegene Inc.
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Applied BioCode
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Cepheid (a Danaher company)
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 Randox Laboratories Ltd
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 AusDiagnostics Pty Ltd
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Genetic Signatures Ltd
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 OpGen Inc.
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Fast Track Diagnostics (a Siemens Healthineers company)
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
